Shalini Bhardwaj

All stories by Shalini Bhardwaj

Omicron cases a wake-up call for India: Expert

Omicron cases a wake-up call for India: Expert

Rediff.com1 days ago

Dr Mishra further explained the effect of hybrid immunity on the vaccinated population and said that it is likely to give protection to people along with the Indian vaccines administered.

Omicron has been around for some time, says SA doctor who raised alarm

Omicron has been around for some time, says SA doctor who raised alarm

Rediff.com3 days ago

Omicron very different from Delta, Beta COVID variants, says South African doctor Angelique Coetzee.

Omicron scare: SII seeks approval for Covishield booster

Omicron scare: SII seeks approval for Covishield booster

Rediff.com4 days ago

The Serum Institute of India is the first Indian company to seek approval for the COVID-19 booster dose.

Centre holds high-level meet as 11 states report serotype-2 dengue cases

Centre holds high-level meet as 11 states report serotype-2 dengue cases

Rediff.com18 Sep 2021

Cabinet Secretary Rajiv Gauba chaired a high-level meet with representatives of states/UTs to also review and discussed the COVID-19 management and response strategy through video conference.

Covid second wave not over yet: Dr Guleria

Covid second wave not over yet: Dr Guleria

Rediff.com13 Aug 2021

The second wave of Coronavirus pandemic is not yet over and the third wave depends on the Covid-19 appropriate behaviour by the people, said Randeep Guleria, the Director of Delhi AIIMS, on Friday.

Vaccine for children over 12 yrs likely by Aug: NTAGI chief

Vaccine for children over 12 yrs likely by Aug: NTAGI chief

Rediff.com27 Jun 2021

Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Covaxin phase 3 trial data to be published in July: Bharat Biotech

Rediff.com9 Jun 2021

Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.